Lewandowski, D.; Konieczny, M.; Chrzanowski, K.; Jakubowska, M.; Paryzek, Z.; Miedziaszczyk, M.; Idasiak-Piechocka, I.
Eculizumab in C3 Glomerulopathy: A Systematic Review of Therapeutic Efficacy and Clinical Outcomes. Pharmaceutics 2025, 17, 1284.
https://doi.org/10.3390/pharmaceutics17101284
AMA Style
Lewandowski D, Konieczny M, Chrzanowski K, Jakubowska M, Paryzek Z, Miedziaszczyk M, Idasiak-Piechocka I.
Eculizumab in C3 Glomerulopathy: A Systematic Review of Therapeutic Efficacy and Clinical Outcomes. Pharmaceutics. 2025; 17(10):1284.
https://doi.org/10.3390/pharmaceutics17101284
Chicago/Turabian Style
Lewandowski, Dominik, Mateusz Konieczny, Krzysztof Chrzanowski, Marta Jakubowska, Zuzanna Paryzek, Miłosz Miedziaszczyk, and Ilona Idasiak-Piechocka.
2025. "Eculizumab in C3 Glomerulopathy: A Systematic Review of Therapeutic Efficacy and Clinical Outcomes" Pharmaceutics 17, no. 10: 1284.
https://doi.org/10.3390/pharmaceutics17101284
APA Style
Lewandowski, D., Konieczny, M., Chrzanowski, K., Jakubowska, M., Paryzek, Z., Miedziaszczyk, M., & Idasiak-Piechocka, I.
(2025). Eculizumab in C3 Glomerulopathy: A Systematic Review of Therapeutic Efficacy and Clinical Outcomes. Pharmaceutics, 17(10), 1284.
https://doi.org/10.3390/pharmaceutics17101284
